Mlu I from New England Biolabs

Anti-Human I-FABP Polyclonal Antibody, Unconjugated from Cell Sciences

ProPrep BAC 960 from Biotech Support Group

ProPrep BAC 960 from Biotech Support Group

Chicken Anti-Plants Thaumatin 2 Polyclonal Antibody, Unconjugated from Abcam

(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated

(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod

(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t

... Minnesota Medical School and Brain Sciences Cente...fied a noninvasive and painless way to diagnose co... at a point of light., The research offers promise...gnosis for brain diseases, as well as a way to mea... these diseases.,Using magnetoencephalography (MEG...

...al Society (ACS) News Service Weekly Press Package...rom scientific presentations scheduled for the ACS...erage of reports from ACS 36 major peer-reviewed j...e with the Aug. 29, 2007 edition. , , ACS NEWS ...OR VARIOUS TIMES AS INDICATED , PressPac Archive:...

...r, younger looking skin, scientists from the Unive...ave made an important discovery toward manipulatin...search range from helping doctors develop more nat...cosmetics companies develop new products for achie...published in the September print issue of The FASE...

(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx

(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,

(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering

(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We